Jon Hawkinson, PhD

Pharmacologist with extensive experience in CNS drug discovery in the pharmaceutical industry. Broad scientific background ranging from target identification to preclinical development, with particular expertise in developing strategies and screening cascades for small molecule lead discovery and optimization. Experienced drug hunter with extensive knowledge of neurological disorders, including pain and neurodevelopmental, neurodegenerative, and neuropsychiatric disorders. Proven track record for progressing projects to candidate delivery including 7 drugs entering Phase I clinical trials, two reaching Phase II, and one FDA-approved drug. Proven performance management and innovative project leadership skills leading productive research groups, project teams, functional areas, collaborations, and external partnerships. More than 70 published research papers, review articles, and patents.

Specialties: Drug Discovery, Pharmacology, High-Throughput Screening, Neuroscience, CNS, Neuropharmacology, Lead Discovery and Optimization, Assay Development, Biochemical, Cellular and Biophysical Assays, Automation, Phenotypic Screening, Small Molecule Lead Discovery and Optimization, Pain, Neurodegeneration, Neurodevelopmental and Neuropsychiatric Disorders, Research Management